NEW YORK (GenomeWeb News) — Cepheid said today that it has made "significant progress" toward fixing manufacturing woes for its Xpert diagnostic test cartridges despite "higher-than-anticipated demand" for a number of its Xpert tests in the fourth quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.